Linex Baby powder for oral suspension 1,000,000,000 CFU/packet in 1.5 g bags 10 pcs.

Composition

active ingredient: Bifidobacterium animalis subsp. lactis;

1 packet (1.5 g) of powder for oral suspension contains 1,000,000,000 CFU of Bifidobacterium animalis subsp. lactis;

excipient: maltodextrin.

Release form

Powder for oral suspension.

Pharmacodynamic parameters. Bifidobacteria – a component of the normal human intestinal microbiota – are among the first to colonize the digestive tract of a newborn, are the dominant intestinal bacteria in breastfed children, and are necessary for the development of the child at an early age.

The protective and therapeutic effect of Bifidobacterium animalis subsp. lactis, which is contained in Linex Baby, is carried out in several ways: the specified strain limits the growth of pathogenic microorganisms in the gastrointestinal tract by preventing their adhesion to the intestinal wall and subsequent colonization, as well as through competitive antagonism for food substrates, the creation of low pH values ​​in the intestinal lumen due to the production of acids, the production of hydrogen peroxide and bacteriocins with antimicrobial properties. In addition, Bifidobacterium animalis subsp. lactis activates the immune response.

Disturbance of the physiological balance of the intestinal microbiota due to the influence of pathogens of a viral or bacterial nature, digestive tract infections, antibiotic and chemotherapy, delayed formation of the normal composition of the intestinal microbiota during the neonatal period causes dyspeptic disorders – the occurrence of increased gas formation in the intestine, colic, defecation disorders, as well as the development of atopic dermatitis.

Thanks to the systematic use of Bifidobacterium animalis subsp. lactis, the frequency of gastrointestinal disorders (diarrhea in particular) resulting from intestinal dysbiosis is effectively reduced; conditions are created for normal intestinal activity. Linex Baby is used for prevention or as a component of complex treatment of atopic dermatitis, or to normalize the activity of the intestinal immune system.

Pharmacokinetic parameters. After administration, Bifidobacterium animalis subsp. lactis causes a local effect in the digestive tract. Pharmacokinetic parameters were not studied, since absorption into the systemic bloodstream does not occur. The resistance of the strain to the effects of gastric juice and bile ensures high survival of Bifidobacterium animalis subsp. lactis when passing through the upper parts of the gastrointestinal tract. Representatives of this strain form a stable adhesion to intestinal mucus and are slowly excreted from the body due to peristaltic contractions and the act of defecation.

In children aged from the 1st day of life to 12 years:

• to normalize and maintain the activity and balance of the intestinal microbiota;
• for prevention and as a supportive agent in case of flatulence, diarrhea or other infectious pathology of the digestive tract of viral or bacterial etiology (including those caused by rotavirus);
• against the background of antimicrobial therapy.

Children – 1 packet during meals. Frequency of administration: from the 1st day of life to 2 years – 1 time per day; at the age of 2-12 years – 1-2 times per day.

Mix the contents of the package with baby food or liquid (milk, juice, water).

^Linex® Baby should not be taken with drinks heated to high temperatures.

The course of Linex Baby can continue until the corresponding manifestations of the disease disappear.

Hypersensitivity to the active pharmaceutical ingredient or maltodextrin.

In rare episodes, hypersensitivity reactions are possible – itching, rash.

In case of fever above 38 °C, diarrhea lasting more than 2 days, severe diarrhea with exsicosis and weight loss, mucus or blood in the stool, intense abdominal pain, if the child has a chronic pathology, such as cardiovascular disease or diabetes, immunodeficiency states (for example, HIV infection), a doctor should be consulted before using the drug.

In children under 6 years of age, diarrhea therapy should be carried out under the supervision of a physician.

When treating diarrhea, adequate correction of water and electrolyte balance is also necessary.

Due to the lack of relevant studies, there is no information on the effect on reaction speed when driving vehicles or other mechanisms.

Not installed.

Due to the sensitivity of bifidobacteria to antibiotics, Linex Baby should be taken 3 hours after using these drugs.

Not found.

At a temperature ≤25 °C in the original packaging, out of the reach of children.